Rather, the evidence for mTOR-signaling as a promising common ASD pathway candidate arise mostly from in vivo research into syndromic autisms such as Tuberous Sclerosis (TS), PTEN-related syndrome, Neurofibromatosis Type 1 (NF-1) and FXS [12,107,108,109]. The gene discussed is PTEN; the disease is autism.